Ursodiol in Huntington's disease

Trial Profile

Ursodiol in Huntington's disease

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2009

At a glance

  • Drugs Ursodeoxycholic acid (Primary)
  • Indications Huntington's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms UDCA-HD
  • Most Recent Events

    • 04 Feb 2009 Planned end date changed from Oct 2008 to Jun 2009 as reported by ClinicalTrials.gov.
    • 04 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 27 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top